Clinical Study

The Association between Intradialytic Hypertension and Metabolic Disorders in End Stage Renal Disease

Table 1

Differences between groups of patients according to the manifestation of intradialytic hypertension in a total of 76 subjects in hemodiafiltration ().

CharacteristicPatients with intradialytic hypertension
Mean ± SD/mean rank
Patients without intradialytic hypertension
Mean ± SD/mean rank
value

Age (years)70.2 ± 14.60.3 ± 14.60.02
Dialysis vintage (years)/45.2/36.90.2
for urea/40.9/37.90.6
nPCR (g/Kg/day)2.1 ± 0.2.4 ± 0.50.03
Urine volume (ml/day)100.5 ±  238.7 ± 147.70.002
BMI (Kg/m2)23.9 ± 3.724.6 ± 2.80.4
Serum bicarbonate (mmol/L)/24.0/42.060.005
i-PTH (pg/ml)/35.7/39.20.6
Calcium corrected to albumin (mg/dl)9.7 ± 0.79.4 ± 0.60.2
P (mg/dl)5.5 ± 1.85.4 ± 1.90.8
Ca × P products53.7 ± 17.150.9 ± 18.10.6
Interdialytic weight gain (liters)2.05 ± 0.92.2 ± 0.90.5
Hb (gr/dl)11.3 ± 1.12.5 ± 1.20.05
Albumin (gr/dl)/35.6/39.20.5
LDL/HDL2.06 ± 0.82.4 ± 0.90.1
c-fPWV (m/s)12.3 ± 2.011.08 ± 1.70.02
Augmentation index (AIx, %)26 ± 2.23.7 ± 1.90.001
Pulse pressure (PP, mmHg)65.2 ± 23.856.5 ± 17.80.1
Percent sodium removal (PSR, %)/46.8/36.50.08
hsCRP (mg/L)8.3 ± 5.67.9 ± 5.90.8